NEW YORK CITY, September 4, 2018 – Empire State Realty Trust, Inc. (NYSE: ESRT) has signed a full floor office lease with ClearView Healthcare Partners for 10,539 sq. ft. at 111 West 33rd Street.
“111 West 33rd Street offers unparalleled convenience to mass transportation, the restaurants of NoMad and Broadway Plaza, and the open space of Greeley Square,” said Thomas P. Durels, Executive Vice President, Real Estate, for ESRT. “Our recently completed new lobby, elevators and entrances designed by STUDIOS Architecture have attracted a great roster of tenants that includes Nespresso and MSG Ventures.”
ClearView Healthcare Partners is a global strategy consulting firm serving the life sciences sector.
David A. Stockel of Transwestern represented ClearView Healthcare Partners in the lease negotiations. Landlord representation was provided by Keith Cody of ESRT, along with Newmark Knight Frank’s Neil Rubin.
About Empire State Realty Trust
Empire State Realty Trust, Inc. (NYSE: ESRT), a leading real estate investment trust (REIT), owns, manages, operates, acquires and repositions office and retail properties in Manhattan and the greater New York metropolitan area, including the Empire State Building, the world’s most famous building. Headquartered in New York, New York, the Company’s office and retail portfolio covers 10.1 million rentable square feet, as of June 30, 2018, consisting of 9.4 million rentable square feet in 14 office properties, including nine in Manhattan, three in Fairfield County, Connecticut, and two in Westchester County, New York; and approximately 700,000 rentable square feet in the retail portfolio.
This press release may contain forward-looking statements within the meaning of the Federal securities laws. You can identify these statements by use of the words “assumes,” “believes,” “estimates,” “expects,” “intends,” “plans,” “projects” and similar expressions that do not relate to historical matters. You should exercise caution in relying on forward-looking statements, because they involve risks, uncertainties and other factors which are, in some cases, beyond ESRT’s control and could materially affect actual results. Such factors and risks include, without limitation, a failure of conditions or performance regarding any event or transaction described above, regulatory changes, and other risks and uncertainties described from time to time in ESRT’s filings with the SEC. Except as may be required by law, ESRT does not undertake a duty to update any forward-looking statement.